Mbrace Therapeutics
MBrace Therapeutics is a privately-held biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets. MBrace is supported by a world-class investor syndicate, including TPG, Avidity Partners, Cowen Healthcare Investments, Venrock and Alta Partners.
7-day free trial · no credit card
Verified contacts
14
available on Kipplo
LinkedIn employees
26
11 to 50 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 14 verified contacts at Mbrace Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
14 contacts with verified email or phone · masked until revealed.
- KB
Kirstin Barnhart
Senior Director, Preclinical Safety · Science
EmailPhone - AA
Allen Albright
Senior Vice President, Regulatory Affairs · Science
EmailPhone - IC
Isan Chen
Chief Executive Officer · General Business & Management
EmailPhone
Showing 3 of 14 verified contacts
Top roles at Mbrace Therapeutics
5 distinct titles indexed · top 5 shown.
- 1associate scientist
- 1board member
- 1chief executive officer
- 1senior director, preclinical safety
- 1senior vice president, regulatory affairs
Sign up to unlock all 14 contacts at Mbrace Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 14 verified contacts at Mbrace Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.